Skip to content

Promotion of Cognitive function like memory, attention and learning among the elderly people

A double blind placebo controlled clinical trial of a ayurveda formulation beneficial in the prevention and management of cognitive deficit disorders

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/01/005351
Enrollment
1000
Registered
2015-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cognitive deficit diosrders

Interventions

Intervention1: Test formulation 500mg twice per day for a period of six months: 500mg capsule was prepared with the help of additive and effective dose of each plant extract was determined during pre-

Sponsors

SRM University
Lead Sponsor
Department of Science Technology
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: A deterioration of memory along with three of the five complaints such as ? 1. Poor orientation 2. Poor judgment 3. Problem solving difficulties 4. Trouble in the functioning of community affairs 5. Inability to function independently in home, during hobbies and personal care were noticed to be present. Dementia rating scale?2 (Jurica 2001). Based on this scale the score obtained for diagnosis of senile dementia of Alzhimer?s type Complaints Normal Control Senile Dementia Attention 79.55 32.22 Initiation/ preservation 23.55 10.04 Construction 21.37 8.93 Conceptualization 2.55 1.45 Memory 21.18 9.79 Total score 10.91 5.87

Exclusion criteria

Exclusion criteria: 1. Endocrine disorder 2. Any chronic illness

Design outcomes

Primary

MeasureTime frame
1. Improves memory and attention span 2. Slowed down the rapid decline of short term memory ad long term memory span. 3. Increases attention span 4. Improved the sleep patternTimepoint: Parameters measured at baseline (Initial), three months and six months

Secondary

MeasureTime frame
Improves anxiety, depression and quality of life in elderly people.Timepoint: Parameters measured at baseline (Initial) and at the interval of every months upto Six months

Countries

India

Contacts

Public ContactDr R Mohankumar

Interdisciplinary School of Indian System of Medicine

ilangok67@gmail.com9444144120

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026